B. Schuster

Tolerability of prophylactic Lariam regimens.

E. Boudreau, B. Schuster, J. Sanchez, 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

Long‐term weight control study V (weeks 190 to 210)

E. C. Stein, M. Averbuch, P. Sundaresan, 1992 .

Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician‐managed behavior modification

E. C. Stein, P. Sundaresan, Michael Weintraub, 1986, Clinical pharmacology and therapeutics.

Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine.

E. C. Stein, M. Moscucci, P. Sundaresan, 1992, Clinical pharmacology and therapeutics.

Long‐term weight control study IV (weeks 156 to 190)

E. C. Stein, M. Averbuch, P. Sundaresan, 1992, Clinical pharmacology and therapeutics.

Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication.

E. C. Stein, M. Averbuch, P. Sundaresan, 1992, Clinical pharmacology and therapeutics.

Long‐term weight control study III (weeks 104 to 156)

E. C. Stein, M. Moscucci, P. Sundaresan, 1992 .

Long‐term weight control study I (weeks 0 to 34)

L. Lasagna, P. Sundaresan, Michael Weintraub, 1992, Clinical pharmacology and therapeutics.

Long‐term weight control study II (weeks 34 to 104)

E. C. Stein, P. Sundaresan, Michael Weintraub, 1992, Clinical pharmacology and therapeutics.

Long‐term weight control study VII (weeks 0 to 210)

P. Sundaresan, Michael Weintraub, B. Schuster, 1992, Clinical pharmacology and therapeutics.